Clorox (CLX) Reports Q2 Revenue About In-Line with Views

Go back to Clorox (CLX) Reports Q2 Revenue About In-Line with Views

Clorox (CLX) PT Lowered to $147 at BMO Capital

February 6, 2018 8:54 AM EST

BMO Capital lowered its price target on Clorox (NYSE: CLX) to $147.00 (from $150.00) while maintaining a Outperform rating.

... More

Clorox (CLX) PT Lowered to $137 at Deutsche Bank on 2Q Report; 'Challenged on the Margin... Near-Term Fundamental Pressures'

February 5, 2018 6:20 AM EST

Deutsche Bank lowered its price target on Clorox (NYSE: CLX) to $137.00 (from $158.00) while maintaining a Hold rating, following the company's second quarter 2018 earnings report.

Analyst Steve Powers notes a cautious outlook on the shares, as CLX reported second quarter revenue results below consensus... More

Buy Clorox (CLX) on Today's Weakness - BMO

February 2, 2018 11:10 AM EST

BMO Capital analyst Shannon Coyne is telling clients to buy Clorox (NYSE: CLX) on today's weakness.

Coyne commented, "CLX reported 2Q/18 adj. EPS of $1.77, beating Consensus/BMO of $1.23/$1.26, though quality was low ($0.61 benefit from a lower effective tax rate) and revenues light. Management raised... More